Risk assets were under pressure after Moderna Chief Executive Stéphane Bancel told the Financial Times that existing COVID-19 vaccines are unlikely to be as effective against the newly detected variant as they have been previously. On the other hand, there are mixed messages with the CEO of BioNTech saying the current generation of Covid-19 vaccines will probably still protect against severe disease in people infected by the omicron variant. However, drugmaker Regeneron Pharmaceuticals Inc said on Tuesday its COVID-19 antibody treatment could be less effective against Omicron.
Nevertheless, the uncertainty has rocked the socks off risk assets. The markets have also got what they were waiting for in Powell’s testimony today, firming the belief that the Fed may still have to hike sooner than first expected despite the threat of the virus. However, it is yet to be seen as to what the Bank of England’s bias will now be.
Inflation has moved sharply higher in the UK, but the BoE has remained firmly with the opinion that inflation will be transitory whereby the three components, food, energy, and autos price has been affected by the supply chain blockages and re-opening of the economy.
Wage data is also mixed, analysts at TD Securities argued. ”Headline wages are distorted by furlough and compositional effects, but underlying pay growth is still rising. Flash October PAYE pay data shows the first drop in median pay since the early days of COVID, as the furlough scheme ended.”
”The BoE’s Dec meeting remains finely balanced. A single hike before March is all but certain, but Omicron may hold the MPC off until February.”
GBP/USD
OVERVIEW
Today last price 1.3253
Today Daily Change -0.0050
Today Daily Change % -0.38
Today daily open 1.3303
TRENDS
Daily SMA20 1.3448
Daily SMA50 1.3579
Daily SMA100 1.369
Daily SMA200 1.3817
LEVELS
Previous Daily High 1.3363
Previous Daily Low 1.3288
Previous Weekly High 1.3457
Previous Weekly Low 1.3278
Previous Monthly High 1.3834
Previous Monthly Low 1.3434
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. . more information you can follow link below